AmirAMoheetMD

Endocrinology • Minneapolis, MN

Diabetes, Lipid Metabolism

Associate Professor of, Medicine, University of Minnesota Medical School, Minneapolis

Join to view full profile

Dr. Moheet is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Moheet's full profile

Already have an account?

Office
420 Delaware St SE
# Mmc
Minneapolis, MN 55455
Phone+1 612-624-5150

Fax+1 612-626-3133

Education & Training

University of MinnesotaFellowship, Endocrinology, Diabetes, and Metabolism, 2009 - 2012
University at BuffaloResidency, Internal Medicine, 2003 - 2006
Dow University of Health SciencesClass of 1999

Certifications & Licensure

MN State Medical License 2009 - 2026
NY State Medical License 2006 - 2009
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Hippocampal Metabolism and Function in Patients With Type 1 Diabetes Start of enrollment: 2013 May 01
Completed
Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia Start of enrollment: 2016 Jun 01
Terminated
Phase 1, Phase 2
Cystic Fibrosis and Cognitive Function Start of enrollment: 2018 May 07
Completed
SGLT2 Inhibitor Therapy in Cystic Fibrosis-related Diabetes Start of enrollment: 2023 Dec 30
RECRUITING
PHASE2, PHASE3
Roles: Contact, Sponsor-Investigator
Join now to see all

Publications & Presentations

PubMed

Hemoglobin A1c in youth and adults with cystic fibrosis related diabetes decreases after elexacaftor-tezacaftor-ivacaftor.
Colleen Wood, Amir Moheet, Tim Vigers, Andrea Granados, Andrea Lorenz
Journal of Cystic Fibrosis. 2025-03-14
Glucagon-like peptide1 receptor agonist treatment of cystic fibrosis-related diabetes complicated by obesity: A cases series and literature review.
Ammar Ahmed, Anvitha Ankireddypalli, Tasma Harindhanavudhi, Antoinette Moran, Amir Moheet
Journal of Clinical & Translational Endocrinology. 2024-12-01
Experimental pharmacological approaches to reverse impaired awareness of hypoglycemia-a review.
Hiba Z Hashmi, Ameer Khowaja, Amir Moheet
Frontiers in Pharmacology. 2024-01-01

Lectures

Naltrexone for Treatment of Hypoglycemia Unawareness in Type 1 Diabetes: A Randomized Clinical Trial
Minneapolis, MN - 6/16/2014
Hippocampal Neurochemical Profile of Subjects with Type 1 Diabetes (T1D) as Measured by ¹H - Magnetic Resonance Spectroscopy (MRS)
Minneapolis, MN - 6/15/2014

Press Mentions

Minneapolis Approves Purchase of Glucometers for Fire DepartmentAugust 8th, 2024